2 active not recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases CNTY-101, IL-2, Lymphodepleting Chemotherapy - Systemic Lupus Erythematosus, Lupus Nephritis | Phase 1 | Active not recruiting | Century Therapeutics, Inc. | 6 | 2025-02-06 | 2026-01-08 |
| CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 KYV-101, Cyclophosphamide, Fludarabine - Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis | Phase 1 | Active not recruiting | David Porter | 24 | 2024-08-05 | 2026-09-21 |
Lupus Nephritis (2) · Myositis (2) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Autoimmune Diseases (1) · Dermatomyositis (1) · Lupus Erythematosus, Systemic (1) · Polymyositis (1) · Scleroderma, Systemic (1) · Sclerosis (1)
Connective Tissue Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Immune System Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nephritis (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Urogenital Diseases (2)
Cyclophosphamide (1) · Interleukin-2 (1) · fludarabine (1)
Century Therapeutics, Inc. (1) · David Porter (1)
United States (2)